Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
04/23/2002 | US6376243 Capable of specifically hybridizing with a sequence included within the sequence of a nucleic acid molecule encoding a mammalian 5-ht4b receptor. |
04/23/2002 | US6376228 Heterophil-adapted poultry vaccine |
04/23/2002 | US6376215 JMY, a co-activator for p300/CBP, nucleic acid encoding JMY and uses thereof |
04/23/2002 | US6376174 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
04/18/2002 | WO2002031168A2 Minimal adenoviral vector and recombinant vaccines based thereon |
04/18/2002 | WO2002031157A2 Shrimp alkaline phosphatase |
04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
04/18/2002 | WO2002030981A1 Gene encoding a human g-protein coupled receptor and its use |
04/18/2002 | WO2002030965A2 Nucleic acids encoding stichodactylidae chromoproteins |
04/18/2002 | WO2002030471A2 A novel system for the evaluation of the activity and/or specificity of a viral component |
04/18/2002 | WO2002030185A1 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same |
04/18/2002 | WO2002030183A1 Genetic control of sex ratio in animal populations |
04/18/2002 | WO2002001949A3 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof |
04/18/2002 | WO2001079452A3 Tolerance-inducing thy-marrow composite tissue construct and organ |
04/18/2002 | WO2001077357A3 Chromosomal vectors and uses thereof |
04/18/2002 | WO2001072777A3 Human transcription factors |
04/18/2002 | WO2001064876A3 Human schizophrenia gene |
04/18/2002 | WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof |
04/18/2002 | US20020046414 In vivo electroporation method for early stage embryo of aves |
04/18/2002 | US20020046412 Use for finding active compounds for crop protection |
04/18/2002 | US20020046411 In vivo animal model of human leukemia |
04/18/2002 | US20020046410 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
04/18/2002 | US20020046409 Roles for Nkx3.1 in prostate development and cancer |
04/18/2002 | US20020045258 Methods to prepare and use epidermal stem cells |
04/18/2002 | US20020045257 Forming embryonic germ cells useful as model for studying imprinting; mate mammals, obtain embryo, dissociate embryonic cells, culturing the dissociated cells |
04/18/2002 | US20020045253 Isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines |
04/18/2002 | US20020045241 T cells specific for kidney carcinoma |
04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
04/18/2002 | US20020045166 Peptides; for use as tools in gene therapy |
04/18/2002 | US20020044946 12-25 kDa bacterial proteins and their 116-58 kDa polymers useful in anti-tumor vaccines |
04/18/2002 | CA2425318A1 Far red shifted fluorescent proteins |
04/18/2002 | CA2425293A1 A novel system for the evaluation of the activity and/or specificity of a viral component |
04/18/2002 | CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation |
04/18/2002 | CA2424901A1 Genetic control of sex ratio in animal populations |
04/18/2002 | CA2424821A1 Gene encoding a human g-protein coupled receptor and its use |
04/18/2002 | CA2393680A1 A schizophrenic model animal with sensorimotor and behavioral abnormalities and a method for preparing the same |
04/17/2002 | EP1197567A2 Characterisation of gene function using double stranded RNA inhibition |
04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
04/17/2002 | EP1197144A1 Transgenic mice and overexpression model of the gene ntrk3 (trkc) based thereon for the study and monitoring of treatments of anxiety, depression and related psychiatric diseases |
04/17/2002 | EP1197143A1 Goodpasture's syndrome model mouse |
04/17/2002 | EP1196635A2 Cell death related drug targets in yeast and fungi |
04/17/2002 | EP1196583A2 GENOME SEQUENCE AND POLYPEPTIDES OF PYROCOCCUS $i(ABISSY), FRAGMENT AND USES THEREOF |
04/17/2002 | EP1196560A1 Neurotrophic factor receptor gfr-alpha-4 |
04/17/2002 | EP1196426A1 Cytoplasmic transfer to de-differentiate recipient cells |
04/17/2002 | EP1196153A2 Process for the improvement of spermatozoa fertilization activity |
04/17/2002 | EP1196027A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
04/17/2002 | EP1196026A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
04/17/2002 | EP0580606B1 Method for delivering the direct feed microorganism lactobacillus reuteri to avian organisms in ovo |
04/17/2002 | CN1344796A Implantation method of sex-linked balance lethal and sex control gene for Bombyx mori |
04/16/2002 | US6374130 Methods for tracking the progression of Alzheimer's disease identifying treatment using transgenic mice |
04/16/2002 | US6372959 Expression vector of a mud loach growth hormone gene |
04/16/2002 | US6372957 Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use |
04/16/2002 | US6372956 Transgenic rats and rat cell lines expressing human CD4 and a human chemokine receptor |
04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
04/16/2002 | US6372422 Creating superovulation in non-human female mammal to create eggs by using an ovulatory pharmaceutical; determining sex of sperm cell of male mammal; sorting according to sex of sperm cells; inserting into uterus; fertilization to produce embryos |
04/11/2002 | WO2002029104A2 Tumor marker and methods of use |
04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
04/11/2002 | WO2002029075A2 Multiple inducible gene regulation system |
04/11/2002 | WO2002029002A2 Method for generating cloned animals using chromosome shuffling |
04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
04/11/2002 | WO2002028891A2 Listeria inocua, genome and applications |
04/11/2002 | WO2002028311A1 System of hysteroscopic insemination of mares |
04/11/2002 | WO2002028188A1 Derivation of human tumor cell lines using passage in transgenic mice having selectable markers |
04/11/2002 | WO2002028164A2 Cloning endangered and extinct species |
04/11/2002 | WO2002012441A3 Cryopreservation of sperm |
04/11/2002 | WO2002009650A3 Methods and compositions for the repair and/or regeneration of damaged myocardium |
04/11/2002 | WO2002003911A3 Prevention and treatment of alzheimer's disease |
04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
04/11/2002 | WO2001070174A3 Vegf-modulated genes and methods employing them |
04/11/2002 | CA2425100A1 Method for generating cloned animals using chromosome shuffling |
04/11/2002 | CA2425076A1 Cloning endangered and extinct species |
04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
04/11/2002 | CA2424178A1 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
04/11/2002 | CA2424115A1 System of hysteroscopic insemination of animals |
04/10/2002 | EP1195435A1 Truncated phosphodiesterase-7 polypeptides |
04/10/2002 | EP1194570A1 Fusion proteins incorporating lysozyme |
04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
04/10/2002 | EP1194447A2 Novel potassium channels and genes encoding these potassium channels |
04/10/2002 | EP1021717B1 Method of sorting birds in ovo |
04/10/2002 | CN2484743Y Silkworm hatcher |
04/10/2002 | CN1082337C Feeds compsn and nutritious agent contg. triterpenic saponin extract |
04/09/2002 | US6369295 Uses of transgenic mouse containing a type X collagen mutant |
04/09/2002 | US6369294 Isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines |
04/09/2002 | US6369059 Tetracyclic derivatives, process of preparation and use |
04/09/2002 | US6369027 Osteoprotegerin |
04/09/2002 | US6368842 An isolated nucleic acid; therapy for neuroblastomas in infant brains, uterus, lung, ovary adenocarcinomas and leukocytes |
04/09/2002 | US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences |
04/09/2002 | US6368811 Syndecan interacting proteins and the use thereof |
04/09/2002 | US6368572 Use of hematopoietic deficient cell transplanted chimeric nonhuman mammals as human bacterial toxin shock models |
04/09/2002 | CA1341356C Transkaryotic implantation |
04/06/2002 | CA2358239A1 Novel siglec-like gene |
04/06/2002 | CA2358235A1 Novel siglec gene |
04/04/2002 | WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
04/04/2002 | WO2002026954A2 Truncated phosphodiesterase-7 polypeptides |
04/04/2002 | WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
04/04/2002 | WO2002026820A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
04/04/2002 | WO2002026805A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
04/04/2002 | WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
04/04/2002 | WO2001094610A3 Binary hybrid mutational vectors |
04/04/2002 | WO2001091575A8 Animal food and method |